Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: Implications for dobutamine stress testing

Circulation

Volumn 96, Issue 7, 1997, Pages 2353-2360

  Calnon, Dennis A ^a   Glover, David K ^a,b   Beller, George A ^a   Vanzetto, Gérald ^a   Smith, William H ^a   Watson, Denny D ^a   Ruiz, Mirta ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Imaging; Inotropic agents; Radioisotopes; Stunning, myocardial

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DRUG UPTAKE; ECHOCARDIOGRAPHY; EXERCISE TEST; FLOW MEASUREMENT; HEART PERFUSION; IMAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0030851690     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2353     Document Type: Article

References (31)

1. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation. 1995;91:813-820.
2. Hartley C, Latson L, Michael L, Seidel C, Lewis R, Entman M. Doppler measurement of myocardial thickening with a single epicardial transducer. Am J Physiol. 1983;245:H1066-H1072.
3. Zhu WX, Myers ML, Hartley CJ, Roberts R, Bolli R. Validation of a single crystal for measurement of transmural and epicardial thickening. Am J Physiol. 1986;251:H1045-H1055.
4. Carstensen S, Ali SM, Stensgaard-Hansen FV, Toft J, Haunsø S, Kelbæk H, Saunamäki K. Dobutamine-atropine stress echocardiography in asymptomatic healthy individuals: the relativity of stress-induced hyperkinesia. Circulation. 1995;92:3453-3463.
5. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79.
6. Gosselin RE, Stibitz GR. Rates of solute absorption from tissue depots: theoretical considerations. Pflugers Arch. 1970;318:85-98.
7. Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol. 1994;1:94-111.
8. Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 1987;76: 943-951.
9. Krivokapich J, Czernin J, Schelbert H. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol. 1996;28:565-572.
10. Severi S, Underwood R, Mohiaddin RH, Boyd H, Paterni M, Camici PG. Dobutamine stress: effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol. 1995;26:1187-1195.
11. Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol. 1993;71:1351-1356.
12. Segar DS, Ryan T, Sawada SG, Johnson M, Feigenbaum H. Pharmacologically induced myocardial ischemia: a comparison of dobutamine and dipyridamole. J Am Soc Echocardiogr. 1995;8:9-14.
13. Zhang J, Path G, Chepuri V, Homans DC, Merkle H, Hendrich K, Ugurbil K, Bache RJ. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implications with regard to dobutamine stress testing. Am Heart J. 1995;129:330-342.
14. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxy-isobutyl isonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826-1838.
15. Yun JJ, Wu JC, Heller EN, Deckelbaum LI, Dione DP, Liu Y, Wackers FJT, Sinusas AJ. Dobutamine stress has limited value for enhancing flow heterogeneity in the presence of a moderate stenosis when used in conjunction with Tc-99m sestamibi imaging. J Am Coll Cardiol. 1995:217A. Abstract.
16. Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med. 1993;20:20-25.
17. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med. 1990;31:464-472.
18. 99mTc-MIBI single photon emission computed tomography. Circulation. 1993;87:345-354.
19. Herman SD, LaBresh KA, Santos-Ocampo CD, Garber CE, Barbour MM, Messinger DE, Cloutier DJ, Ahlberg AW, Heller GV. Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol. 1994;73:164-169.
20. 99mTc-MIBI single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses. Eur J Nucl Med. 1994;21:537-544.
21. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J. 1994;128:713-718.
22. Günalp B, Dokumaci B, Uyan C, Varderelî E, Isik E, Bayhan H, Özgüven M, Öztürk E. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med. 1993;34:889-894.
23. Baer FM, Voth E, Theissen P, Schneider CA, Schicha H, Sechtem U. Coronary artery disease: findings with GRE MR imaging and Tc-99m methoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress. Radiology. 1994;193:203-209.
24. Forster T, McNeill AJ, Salustri A, Reijs AEM, El-Said ESM, Roelandt JRTC, Fioretti PM. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 1993;21:1591-1596.
25. Mairesse GH, Marwick TH, Vanoverschelde JLJ, Baudhuin T, Wijns W, Melin JA, Detry JMR. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (MIBI) perfusion scintigraphy. J Am Coll Cardiol. 1994;24:920-927.
26. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993;22:159-167.
27. Di Bello V, Bellina CR, Gori E, Molea N, Talarico L, Boni G, Magagnini E, Matteucci F, Giorgi D, Lazzeri E, Bertini A, Romano MF, Bianchi R, Giusti C. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease. J Nucl Cardiol. 1996;3:212-220.
28. Iftikhar I, Koutelou M, Mahmarian JJ, Verani MS. Simultaneous perfusion tomography and radionuclide angiography during dobutamine stress. J Nucl Med. 1996;37:1306-1310.
29. 99mTc-sestamibi defect size. Circulation. 1993;88:2224-2234.
30. Hoffman R, Lethen H, Marwick T, Arnese M, Fioretti P, Pingatore A, Picano E, Buck T, Erbel R, Flachskampf FA, Hanrath P. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 1996;27: 330-336.
31. Ambrosio G, Betocchi S, Pace L, Losi MA, Perrone-Filardi P, Soricelli A, Piscione F, Taube J, Squame F, Salvatore M, Weiss JL, Chiariello M. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: evidence of myocardial stunning in patients with coronary artery disease. Circulation. 1996;94:2455-2464.